Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN Clinical Trials in Tianjin, Tianjin Municipality

Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial